The currently used treatments for AD rely on the use of AChE inhibitors because acetylcholine levels in the brain increase secondary to the inhibition of the enzyme which catalyzes its breakdown, and normal function of the cholinergic system in the brain is maintained [4,7,8]. Here, ACHE is linked to Alzheimer disease.